skip to main content
Idioma:
Primo Advanced Search
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search prefilters
Búsqueda Sencilla
Mostrar solo
Refinado por: colección: EBSCOhost Academic Search Premier eliminar
Result Number Material Type Add to My Shelf Action Record Details and Options
1
A 5-Drug Regimen Maximizing the Dose of Cyclophosphamide is Effective Therapy for Adult Burkitt or Burkitt-like Lymphomas
A 5-Drug Regimen Maximizing the Dose of Cyclophosphamide is Effective Therapy for Adult Burkitt or Burkitt-like Lymphomas
Material Type:
Artículo 		Añadir a Mi Portal

A 5-Drug Regimen Maximizing the Dose of Cyclophosphamide is Effective Therapy for Adult Burkitt or Burkitt-like Lymphomas

Kujawski, Lisa A. ; Longo, Walter L. ; Williams, Eliot C. ; Turman, Nancy J. ; Brandt, Nancy ; Mosher, Deane F. ; Eickhoff, Jens C. ; Kahl, Brad S.

Cancer investigation, 2007-01, Vol.25 (2), p.87-93 [Revista revisada por pares]

England: Informa UK Ltd

Texto completo disponible

Citas Citado por
2
Aberrant cytokine signaling in leukemia
Aberrant cytokine signaling in leukemia
Material Type:
Artículo 		Añadir a Mi Portal

Aberrant cytokine signaling in leukemia

Van Etten, R A

Oncogene, 2007-10, Vol.26 (47), p.6738-6749 [Revista revisada por pares]

England: Nature Publishing Group

Texto completo disponible

Citas Citado por
3
Aberrant expression of CD123 (interleukin-3 receptor-α) on neoplastic mast cells
Aberrant expression of CD123 (interleukin-3 receptor-α) on neoplastic mast cells
Material Type:
Artículo 		Añadir a Mi Portal

Aberrant expression of CD123 (interleukin-3 receptor-α) on neoplastic mast cells

Pardanani, A ; Lasho, T ; Chen, D ; Kimlinger, T K ; Finke, C ; Zblewski, D ; Patnaik, M M ; Reichard, K K ; Rowinsky, E ; Hanson, C A ; Brooks, C ; Tefferi, A

Leukemia, 2015-07, Vol.29 (7), p.1605-1608 [Revista revisada por pares]

England: Nature Publishing Group

Texto completo disponible

Citas Citado por
4
ABO, alemtuzumab and allogeneic transplantation
ABO, alemtuzumab and allogeneic transplantation
Material Type:
Artículo 		Añadir a Mi Portal

ABO, alemtuzumab and allogeneic transplantation

Cooling, L

Bone marrow transplantation (Basingstoke), 2015-07, Vol.50 (7), p.881-883 [Revista revisada por pares]

England: Nature Publishing Group

Texto completo disponible

Citas Citado por
5
ABO, alemtuzumab and allogeneic transplantation: this article has been corrected since Advance Online Publication and a corrigendum is also printed in this issue
ABO, alemtuzumab and allogeneic transplantation: this article has been corrected since Advance Online Publication and a corrigendum is also printed in this issue
Material Type:
Artículo 		Añadir a Mi Portal

ABO, alemtuzumab and allogeneic transplantation: this article has been corrected since Advance Online Publication and a corrigendum is also printed in this issue

Cooling, L

Bone marrow transplantation (Basingstoke), 2015-07, Vol.50 (7), p.881 [Revista revisada por pares]

Nature Publishing Group

Texto completo disponible

Citas Citado por
6
Achievement of a negative minimal residual disease state after hypomethylating agent therapy in older patients with AML reduces the risk of relapse
Achievement of a negative minimal residual disease state after hypomethylating agent therapy in older patients with AML reduces the risk of relapse
Material Type:
Artículo 		Añadir a Mi Portal

Achievement of a negative minimal residual disease state after hypomethylating agent therapy in older patients with AML reduces the risk of relapse

Boddu, P ; Jorgensen, J ; Kantarjian, H ; Borthakur, G ; Kadia, T ; Daver, N ; Alvarado, Y ; Pemmaraju, N ; Bose, P ; Naqvi, K ; Yilmaz, M ; Pierce, S ; Brandt, M ; DiNardo, C D ; Jabbour, E J ; Konopleva, M ; Garcia-Manero, G ; Cortes, J ; Ravandi, F

Leukemia, 2018-01, Vol.32 (1), p.241-244 [Revista revisada por pares]

England: Nature Publishing Group

Texto completo disponible

Citas Citado por
7
Activation of the NF- B pathway by the leukemogenic TEL-Jak2 and TEL-Abl fusion proteins leads to the accumulation of antiapoptotic IAP proteins and involves IKK
Activation of the NF- B pathway by the leukemogenic TEL-Jak2 and TEL-Abl fusion proteins leads to the accumulation of antiapoptotic IAP proteins and involves IKK
Material Type:
Artículo 		Añadir a Mi Portal

Activation of the NF- B pathway by the leukemogenic TEL-Jak2 and TEL-Abl fusion proteins leads to the accumulation of antiapoptotic IAP proteins and involves IKK

Malinge, S ; Monni, R ; Bernard, O ; Penard-Lacronique, V

Oncogene, 2006-06, Vol.25 (25), p.3589-3597 [Revista revisada por pares]

New York: Nature Publishing Group

Texto completo disponible

Citas Citado por
8
Activation of the NF-κB pathway by the leukemogenic TEL-Jak2 and TEL-Abl fusion proteins leads to the accumulation of antiapoptotic IAP proteins and involves IKKα
Activation of the NF-κB pathway by the leukemogenic TEL-Jak2 and TEL-Abl fusion proteins leads to the accumulation of antiapoptotic IAP proteins and involves IKKα
Material Type:
Artículo 		Añadir a Mi Portal

Activation of the NF-κB pathway by the leukemogenic TEL-Jak2 and TEL-Abl fusion proteins leads to the accumulation of antiapoptotic IAP proteins and involves IKKα

MALINGE, S ; MONNI, R ; BERNARD, O ; PENARD-LACRONIQUE, V

Oncogene, 2006-06, Vol.25 (25), p.3589-3597 [Revista revisada por pares]

Basingstoke: Nature Publishing

Texto completo disponible

Citas Citado por
9
Acute Myeloid Leukemia Genetics: Risk Stratification and Implications for Therapy
Acute Myeloid Leukemia Genetics: Risk Stratification and Implications for Therapy
Material Type:
Artículo 		Añadir a Mi Portal

Acute Myeloid Leukemia Genetics: Risk Stratification and Implications for Therapy

Wang, Michael L ; Bailey, Nathanael G

Archives of pathology & laboratory medicine (1976), 2015-10, Vol.139 (10), p.1215-1223 [Revista revisada por pares]

United States: College of American Pathologists

Texto completo disponible

Citas Citado por
10
Acute myeloid leukemia-targeted toxin activates both apoptotic and necroptotic death mechanisms
Acute myeloid leukemia-targeted toxin activates both apoptotic and necroptotic death mechanisms
Material Type:
Artículo 		Añadir a Mi Portal

Acute myeloid leukemia-targeted toxin activates both apoptotic and necroptotic death mechanisms

Horita, Henrick ; Frankel, Arthur E ; Thorburn, Andrew Najbauer, Joseph

PloS one, 2008-12, Vol.3 (12), p.e3909-e3909 [Revista revisada por pares]

United States: Public Library of Science

Texto completo disponible

Citas Citado por

Personalizar los resultados

  1. Editar

Refine Search Results

Ampliar mis resultados

  1.   

Mostrar solo

  1. Revistas arbitradas (664)

Refinar mis resultados

Tipo de Recurso 

  1. Artículos  (667)
  2. Informes  (4)
  3. magazinearticle  (4)
  4. Reseñas  (1)
  5. Más opciones open sub menu

Fecha de Publicación 

De Hasta
Refinar
  1. Antes de1998  (6)
  2. 1998Hasta2003  (52)
  3. 2004Hasta2009  (172)
  4. 2010Hasta2016  (257)
  5. Después de 2016  (190)
  6. Más opciones open sub menu

Idioma 

  1. Inglés  (673)
  2. Japonés  (83)
  3. Español  (3)
  4. Portugués  (2)
  5. Más opciones open sub menu

  • Realización: ABCD-USP USP   Logos de Redes Sociales: Freepik

Buscando en bases de datos remotas, por favor espere

  • Buscando por
  • enscope:(USP_VIDEOS),scope:("PRIMO"),scope:(USP_FISICO),scope:(USP_EREVISTAS),scope:(USP),scope:(USP_EBOOKS),scope:(USP_PRODUCAO),primo_central_multiple_fe
  • Mostrar lo que tiene hasta ahora